Abstract
Objective:
To examine the efficacy of 2 over-the-counter cosmeceutical creams in reducing facial rhytids—Freeze 24/7 Anti-Wrinkle Cream (Freeze 24/7 International LLC, New York, New York) and LiftFusion Micro-Injected M-Tox Transdermal Face Lift (Fusionbeauty, Inc, Boca Raton, Florida)—against placebo (Nutraderm Therapeutic Lotion; Healthpoint, Inc, San Antonio, Texas).
Methods:
A prospective, blinded clinical trial was performed on 42 subjects, comparing 2 cosmeceutical creams that each represent a class of purported rapid rhytid reduction formulas with placebo. Independent analysis by 2 facial plastic surgeons was performed as well as completion of self-assessment questionnaires by the participants.
Results:
No complications occurred. Self-evaluation of cream effectiveness was no different for test creams compared with placebo. Neither cream produced substantial reduction of rhytids when examined critically by 2 independent facial plastic surgeons. Stratification by Glogau (photoaging) class did not reveal increased effectiveness based on rhytid severity.
Conclusion:
Two typical over-the-counter rhytid reduction products are ineffective at substantially reducing facial rhytids.
Get full access to this article
View all access options for this article.